Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Revenues Up, Losses Down in Q4

NEW YORK, Feb. 20 (GenomeWeb News) - Paradigm Genetics yesterday reported improved revenues and considerably narrowed losses for the fourth quarter of 2003.

Revenues increased to $5.5 million, from $1.9 million during the fourth quarter of 2002.

R&D expenses for the quarter increased slightly to $6 million, from $5.7 million the year before.

Net losses amounted to $2.2 million, or $.07 per share, down from $9.3 million, or $.29 per share, during the year-ago period.

As of Dec. 31, Paradigm had cash, cash equivalents, and short-term investments of $10.2 million.

Click  here for the full earnings report.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.